High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Olivier Hermine

Stock and Other Ownership Interests: AB Science

Consulting or Advisory Role: AB Science, Inaherys, BMS (Inst)

Research Funding: AB Science, Inatherys, Novartis, Celgene

Patents, Royalties, Other Intellectual Property: BMS

Jan Walewski

Honoraria: Roche, AbbVie, Gilead Sciences, Novartis

Consulting or Advisory Role: Roche, AbbVie, Takeda/Millennium, Gilead Sciences, Novartis

Research Funding: AstraZeneca/MedImmune, Epizyme, Incyte, Janssen-Cilag, Karyopharm Therapeutics, Loxo/Lilly, NanoVector, MorphoSys, MSD Oncology, Regeneron, Seattle Genetics, Takeda, TG Therapeutics, Vanda Pharmaceuticals (Inst), Bristol Myers Squibb/Celgene, Gilead Sciences, GlaxoSmithKline, Novartis (Inst)

Catherine Thieblemont

Honoraria: Celgene, AbbVie, Bayer, Janssen, Roche, Incyte, Novartis, Gilead Sciences

Research Funding: Roche

Travel, Accommodations, Expenses: Roche, Janssen-Cilag, Kite/Gilead, Novartis, AbbVie

Michal Szymczyk

Employment: Novo Nordisk (I), Merck KGaA (I), GlaxoSmithKline

Gilles Salles

Stock and Other Ownership Interests: Owkin

Honoraria: AbbVie, Bayer, Regeneron, Incyte

Consulting or Advisory Role: Roche/Genentech, Janssen, Novartis, Morphosys, Epizyme, Genmab, Debiopharm Group, Velosbio, BMS, BeiGene, Incyte, Miltenyi Biotec, Ipsen, AbbVie, Kite/Gilead, Loxo/Lilly, Molecular Partners, Nordic Nanovector, RAPT Therapeutics, Takeda, Incyte

Pierre Feugier

Honoraria: Roche/Genentech, Janssen, Gilead Sciences, Amgen, AbbVie, AstraZeneca

Consulting or Advisory Role: Roche/Genentech, Janssen, AbbVie, Gilead Sciences, Amgen, AstraZeneca

Speakers' Bureau: Roche/Genentech, AbbVie, Amgen, Janssen, Gilead Sciences

Research Funding: Roche/Genentech, Gilead Sciences, Janssen, AbbVie, Amgen

Travel, Accommodations, Expenses: Amgen, Gilead Sciences, Janssen, Roche/Genentech, AbbVie

Kai Hübel

Consulting or Advisory Role: Roche, Incyte, EUSA Pharma, AbbVie, Novartis

Speakers' Bureau: BeiGene, Roche, Incyte, EUSA Pharma, Novartis

Research Funding: Incyte

Travel, Accommodations, Expenses: Roche

Corinne Haioun

Honoraria: Roche, Janssen-Cilag, Gilead Sciences, Miltenyi Biotec, Amgen, Takeda, Celgene

René Olivier Casasnovas

Honoraria: Roche/Genentech, Takeda, Gilead Sciences, Bristol Myers Squibb, Merck, AbbVie, Celgene, Janssen, Amgen

Consulting or Advisory Role: Roche/Genentech, Takeda, Gilead Sciences, Bristol Myers Squibb, Merck, AbbVie, Celgene, Janssen, Incyte, ADC Therapeutics

Research Funding: Roche/Genentech (Inst), Gilead Sciences (Inst), Takeda (Inst)

Travel, Accommodations, Expenses: Roche/Genentech, Takeda, Gilead Sciences, Janssen, AbbVie

Christian Schmidt

Honoraria: AstraZeneca

Consulting or Advisory Role: Kite/Gilead, Novartis, Bristol Myers Squibb

Travel, Accommodations, Expenses: Kite/Gilead

Kamal Bouabdallah

Honoraria: Roche, Takeda Science Foundation, AbbVie, Kite/Gilead

Consulting or Advisory Role: Roche, Takeda, Kite/Gilead

Travel, Accommodations, Expenses: Roche, Takeda

Vincent Ribrag

Honoraria: AZD, Infinity Pharmaceuticals, Gilead Sciences, NanoString Technologies, Roche, Novartis, AbbVie

Consulting or Advisory Role: Infinity Pharmaceuticals, PharmaMar, Gilead Sciences, NanoString Technologies, Bristol Myers Squibb, MSD, Roche/Genentech, Immune Design, Roche, Incyte

Research Funding: arGEN-X BVBA, Epizyme (Inst), Argenx (Inst), Astex Pharmaceuticals (Inst), GlaxoSmithKline/Adaptimmune (Inst)

Expert Testimony: Servier

Travel, Accommodations, Expenses: Roche, Bristol Myers Squibb, Bristol Myers Squibb, AZD

Lothar Kanz

Stock and Other Ownership Interests: Curevac

Honoraria: MedUdate

Travel, Accommodations, Expenses: MedUdate

Jan Dürig

Consulting or Advisory Role: BMS GmbH & Co KG, Celgene, Janssen, Amgen, Takeda, Roche

Speakers' Bureau: Amgen, BMS GmbH & Co KG, Janssen

Travel, Accommodations, Expenses: Janssen, BMS GmbH & Co KG

David Sibon

Consulting or Advisory Role: Takeda, Janssen, Roche, AbbVie

Travel, Accommodations, Expenses: Takeda, Janssen

Morgane Cheminant

Honoraria: CSL Behring

Wolfram Klapper

Honoraria: Amgen, Takeda, Roche (Inst), Roche (Inst), Roche/Genentech (Inst), EUSA Pharma (Inst)

Research Funding: Regeneron (Inst), Takeda (Inst), Roche (Inst), Amgen (Inst), Bayer (Inst)

Michael Unterhalt

Uncompensated Relationships: Roche (Inst), Janssen Cilag GmbH (Inst), Roche Pharma AG (Inst), Bayer (Inst)

Martin Dreyling

Honoraria: Astra Zeneca, Beigene, Gilead/Kite, Janssen, Lilly, Novartis, Roche

Consulting or Advisory Role: Astra Zeneca, Beigene, BMS/Celgene, Gilead/Kite, Janssen, Lilly/Loxo, Novartis, Roche

Research Funding: Abbvie (Inst), Bayer (Inst), BMS/Celgene (Inst), Gilead/Kite (Inst), Janssen (Inst), Roche (Inst)

Travel, Accommodations, Expenses: Gilead/Kite, Janssen-Cilag, Roche Pharma AG

No other potential conflicts of interest were reported.